integrating immuno-oncology and targeted therapy for bladder cancer in practice
Published 4 years ago • 25 plays • Length 9:43Download video MP4
Download video MP3
Similar videos
-
0:55
targeted therapy option of erdafitinib in bladder cancer #oncology #cancer #2023
-
6:30
new data on immunotherapy for bladder cancer - part 1.mp4
-
6:24
new data on immunotherapy for bladder cancer - part 1
-
8:14
an integrated approach to bladder cancer
-
5:50
ongoing immuno-oncology research in bladder cancer
-
1:14
targeted therapy and immunotherapy combination for bladder cancer treatment
-
5:04
immunotherapy for bladder cancer review with dr. andrea apolo—practiceupdate's esmo coverage
-
3:56
an overview of immunotherapy in bladder cancer.mp4
-
1:08
incorporating immunotherapy in the treatment of early-stage bladder cancer
-
1:08
incorporating immunotherapy in the frontline treatment of patients with bladder cancer
-
3:59
pembrolizumab and ido inhibitors in bladder cancer
-
2:03
the evolution of bladder cancer treatment and the immuno-oncology era
-
1:08
future treatment approaches for patients with bladder cancer
-
5:54
esmo 2018: immunotherapy in the neoadjuvant setting for bladder cancer
-
2:41
should pd-l1 be used as a biomarker for immunotherapy in bladder cancer?
-
14:16
new emerging treatment options and targeted therapies for bladder cancer
-
6:58
promising treatment options for advanced bladder cancer
-
1:34
dr. tyson on rationale for neoadjuvant chemotherapy in bladder cancer
-
1:34
dr. singh on patient selection for immunotherapy in bladder cancer